ArticleCells2026
Identifying Transcription Factors Distinguishing Regenerating Cardiomyocytes in the Zebrafish Heart Using Single-Cell Transcriptomics.
Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Mammalian hearts exhibit limited regeneration, whereas zebrafish hearts present a remarkable capacity to regenerate upon injury through cardiomyocyte (CM) proliferation. Thus, understanding genes and especially transcription factors (TFs) enabling zebrafish CM regeneration may open new avenues for human heart repair. Herein, we injured zebrafish hearts by apex resection (AR) and found that the number of cycling CMs peaked around 7-14 days post-injury (dpi). Single-photon confocal imaging of 3D zebrafish hearts confirmed cycling cardiac cells throughout the heart at 7 dpi, while flow cytometry estimated that 1-2% of CMs were cycling. High-resolution single-cell RNA sequencing identified a CM cluster exclusively present after AR, whereas differential gene expression profiling identified genes defining this AR-specific CM cluster. Yet, overexpression of a single gene hit, Anxa2a, in mouse CMs did not override the inability of mammalian CMs to re-enter cell cycling. Instead, we outlined predicted upstream TFs responsible for the observed gene expression profile in the AR-specific CMs and, by proof-of-concept, overexpressed two predicted TF hits, Insm1 (Insulinoma-associated protein 1) and Tead1 (TEA Domain transcription factor 1) in mouse CMs. Notably, both Insm1 and Tead1 doubled the number of cycling mouse CMs, and despite that this induction was modest, CyclinB1 and Aurkb levels increased, pointing towards mouse CM division rather than a stimulation of polyploidy. In summary, we provide a new network of TFs predicted to regulate an AR-specific CM population in zebrafish that may be further explored to unravel zebrafish heart regeneration and eventually utilized for inducing CM proliferation in the mammalian heart.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.